Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Cyclically Adjusted PS Ratio: (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
58 GF Score
Price NT$32.10
GF Value NT$39.16
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio Related Terms


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 3.32 2.69 1.54 1.11

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.14 1.15 1.11 0.00

TPE:1762 vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio falls into.


TPE:1762
58GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Chunghwa Chemical Synthesis & Biotech Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.539/330.2130*330.2130
=6.539

Current CPI (Mar. 2026) = 330.2130.

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.825 241.018 5.241
201609 4.309 241.428 5.894
201612 3.867 241.432 5.289
201703 3.510 243.801 4.754
201706 2.523 244.955 3.401
201709 4.636 246.819 6.202
201712 4.365 246.524 5.847
201803 3.536 249.554 4.679
201806 4.232 251.989 5.546
201809 2.295 252.439 3.002
201812 2.904 251.233 3.817
201903 4.392 254.202 5.705
201906 4.038 256.143 5.206
201909 2.809 256.759 3.613
201912 3.514 256.974 4.516
202003 3.940 258.115 5.041
202006 5.047 257.797 6.465
202009 3.639 260.280 4.617
202012 7.024 260.474 8.905
202103 5.395 264.877 6.726
202106 6.410 271.696 7.791
202109 6.489 274.310 7.811
202112 6.427 278.802 7.612
202203 6.753 287.504 7.756
202206 7.444 296.311 8.296
202209 5.942 296.808 6.611
202212 6.890 296.797 7.666
202303 9.787 301.836 10.707
202306 6.757 305.109 7.313
202309 4.298 307.789 4.611
202312 5.873 306.746 6.322
202403 3.227 312.332 3.412
202406 5.908 314.175 6.210
202409 4.649 315.301 4.869
202412 3.692 315.605 3.863
202503 3.428 319.799 3.540
202506 6.183 322.561 6.330
202509 2.793 324.800 2.840
202512 2.049 324.054 2.088
202603 6.539 330.213 6.539

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be undervalued. The current stock price of NT$32.10 is trading 18% below its estimated GF Value™ of NT$39.16. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:1762:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: NT$39.16 vs. price of NT$32.10 (18% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
58GF Score

Get the complete analysis for TPE:1762

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.10
Price
NT$39.16
GF Value